| 000 | 01850 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517171913.0 | ||
| 264 | 0 | _c20190415 | |
| 008 | 201904s 0 0 eng d | ||
| 022 | _a2045-2322 | ||
| 024 | 7 |
_a10.1038/s41598-017-09983-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLin, Yu-Wei | |
| 245 | 0 | 0 |
_aCo-delivery of paclitaxel and cetuximab by nanodiamond enhances mitotic catastrophe and tumor inhibition. _h[electronic resource] |
| 260 |
_bScientific reports _c08 2017 |
||
| 300 |
_a9814 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aCetuximab _xadministration & dosage |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDrug Carriers |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 |
_aErbB Receptors _xgenetics |
| 650 | 0 | 4 | _aGene Expression |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMitosis _xdrug effects |
| 650 | 0 | 4 |
_aNanodiamonds _xchemistry |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aRaj, Emmanuel Naveen | |
| 700 | 1 | _aLiao, Wei-Siang | |
| 700 | 1 | _aLin, Johnson | |
| 700 | 1 | _aLiu, Kuang-Kai | |
| 700 | 1 | _aChen, Ting-Hua | |
| 700 | 1 | _aCheng, Hsiao-Chun | |
| 700 | 1 | _aWang, Chi-Ching | |
| 700 | 1 | _aLi, Lily Yi | |
| 700 | 1 | _aChen, Chinpiao | |
| 700 | 1 | _aChao, Jui-I | |
| 773 | 0 |
_tScientific reports _gvol. 7 _gno. 1 _gp. 9814 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41598-017-09983-8 _zAvailable from publisher's website |
| 999 |
_c27508559 _d27508559 |
||